However, STING signaling is defective in human DU145 PCa cells due to the Janus kinase 2 (JAK2)/STAT3 pathway, and STING agonists fail to provoke the cGAS-STING pathway and promote the production of type I IFN. The gene discussed is STING1; the disease is posterior cortical atrophy.